Updated

Shares of Tempus AI jumped roughly 30% over the course of the week after Morgan Stanley raised its revenue outlook for the healthcare AI company. The upgrade points to growing analyst confidence in Tempus AI's commercial trajectory within the health-technology sector. The rally adds Tempus AI to a list of AI-linked healthcare names drawing renewed investor enthusiasm following positive analyst commentary.